Cart
sales@molnova.com
Frangufoline
CAS No. 19526-09-1
Frangufoline( ——— )
Catalog No. M38971 CAS No. 19526-09-1
Frangufoline is a 4(14)-type cyclopeptide alkaloid, that can be isolated from the root bark extract of Ziziphus cambodiana Pierre.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFrangufoline
-
NoteResearch use only, not for human use.
-
Brief DescriptionFrangufoline is a 4(14)-type cyclopeptide alkaloid, that can be isolated from the root bark extract of Ziziphus cambodiana Pierre.
-
DescriptionFrangufoline is a sedative 14-membered frangulanine-type cyclopeptide alkaloid.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number19526-09-1
-
Formula Weight534.701
-
Molecular FormulaC31H42N4O4
-
Purity>98% (HPLC)
-
SolubilityH2O : 5 mg/mL (9.35 mM; ultraphonic)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lomchoey N, et al. New bioactive cyclopeptide alkaloids with rare terminal unit from the root bark of Ziziphus cambodiana. RSC Adv. 2018 May 17;8(33):18204-18215. ?
molnova catalog
related products
-
N3-C5-NHS ester
N3-C5-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
-
BC-LI-0186
BC-LI-0186 is a potent and selective inhibitor of the interaction of Leucyl-tRNA synthetase (LRS) and Ras-related GTP-binding protein D (RagD) with IC50 of 46.11 nM.
-
Astegolimab
Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.
